跳至主要内容
临床试验/CTRI/2024/07/071615
CTRI/2024/07/071615尚未招募2 期

Effect of Brinjasif in management of premenstrual syndrome (PMS): A double-blind, randomized placebo-controlled trial - NI

uqman Unani Medical College Hospital and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Subject irrespective of their marital status, between 18-40 years having regular menstrual cycle of 21-35days.
  • 2) Presenting with signs and symptoms of PMS for atleast 3 menstrual cycles as per ACOG guidelines.

排除标准

  • Patients with 1) Irregular menstrual cycle. 2) Pregnancy, lactating and women on OCPs, HRT. 3) Diagnosed case of psychiatric disease. 4) Women with uncontrolled endocrine illness (DM, THYROID DISEASE, HTN).

研究者

发起方
uqman Unani Medical College Hospital and Research Centre

相似试验